See how top analysts and institutions rate COST — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Oppenheimer | Reiterated | Outperform | $1130 → $1050 | 2025-11-03 |
| BTIG Research | Initiated | Buy | $1115 | 2025-10-15 |
| Wolfe Research | Resumed | Peer Perform | 2025-09-18 | |
| Erste Group | Downgrade | Buy → Hold | 2025-08-05 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 3 | 18 | 15 | 1 | 0 |
| October 2025 | 3 | 19 | 14 | 1 | 0 |
| September 2025 | 3 | 18 | 14 | 1 | 0 |
| August 2025 | 4 | 17 | 14 | 1 | 0 |
The majority of institutional investors have issued a "Buy" rating for COST, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.